Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling.

Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling.
复制标题

DOI:
10.1016/j.ccr.2010.10.013
复制
发表时间:
2010-11-16
期刊:
影响因子:
50.3
通讯作者:
Green AR
Green AR
中科院分区:
医学1区
文献类型:
--
作者:
Chen E;Beer PA;Godfrey AL;Ortmann CA;Li J;Costa-Pereira AP;Ingle CE;Dermitzakis ET;Campbell PJ;Green AR

文献摘要

参考文献

被引文献

相似文献

JAK2V617F突变与不同的骨髓增生性肿瘤相关,包括真性红细胞增多症(PV)和原发性血小板增多症(ET),但仍不清楚它如何产生不同的疾病。通过比较来自个体患者的克隆衍生的突变体和野生型细胞,我们证明JAK2V617F的转录后果是微妙的,并且来自ET和PV患者的JAK2V617F杂合红系细胞表现出差异干扰素信号传导和STAT1磷酸化。正常CD34阳性祖细胞中STAT1活性增加产生ET样表型,而JAK2V617F杂合ET祖细胞中STAT1活性下调产生PV样表型。我们的结果说明了克隆分析的力量,表明JAK2V617F的结果反映了STAT5和STAT1激活之间的平衡,并与其他与信号通路突变相关的肿瘤相关。
The JAK2V617F mutation is associated with distinct myeloproliferative neoplasms, including polycythemia vera (PV) and essential thrombocythemia (ET), but it remains unclear how it generates disparate disorders. By comparing clonally-derived mutant and wild-type cells from individual patients, we demonstrate that the transcriptional consequences of JAK2V617F are subtle, and that JAK2V617F-heterozygous erythroid cells from ET and PV patients exhibit differential interferon signaling and STAT1 phosphorylation. Increased STAT1 activity in normal CD34-positive progenitors produces an ET-like phenotype, whereas down-regulation of STAT1 activity in JAK2V617F-heterozygous ET progenitors produces a PV-like phenotype. Our results illustrate the power of clonal analysis, indicate that the consequences of JAK2V617F reflect a balance between STAT5 and STAT1 activation and are relevant for other neoplasms associated with signaling pathway mutations.
DOI: 10.1016/s0140-6736(05)67785-9
发表时间: 2005-12-03
期刊: LANCET
影响因子: 168.9
作者:
Campbell, PJ;Scott, LM;Green, AR
通讯作者: Green, AR
DOI: 10.1371/journal.pgen.1000692
发表时间: 2009-10
期刊: PLoS genetics
影响因子: 4.5
作者:
Gerrits A;Li Y;Tesson BM;Bystrykh LV;Weersing E;Ausema A;Dontje B;Wang X;Breitling R;Jansen RC;de Haan G
通讯作者: de Haan G
DOI: 10.1182/blood-2009-04-215848
发表时间: 2010-04-29
期刊: BLOOD
影响因子: 20.3
作者:
Akada, Hajime;Yan, Dongqing;Mohi, M. Golam
通讯作者: Mohi, M. Golam
DOI: 10.1111/j.1365-2141.2009.07870.x
发表时间: 2009-11-01
影响因子: 6.5
作者:
Grimwade, Lizz F.;Happerfield, Lisa;Erber, Wendy N.
通讯作者: Erber, Wendy N.
DOI: 10.1056/nejmoa043800
发表时间: 2005-07-07
影响因子: 158.5
作者:
Harrison, CN;Campbell, PJ;Murray, M
通讯作者: Murray, M